Thursday, 15 October 2026European Markets

VERALLIA And SMURFIT KAPPA GP Have A High Dividend Yield And Return On Equity In The Consumer Cyclical Sector.

Loading stream...

(vianews) - verallia (vrla.pa) is among this list of stock assets with the highest dividend rate and return on equity on the consumer cyclical sector.

financial asset price forward dividend yield return on equity
verallia (vrla.pa) €41.28 4.13% 38.09%
smurfit kappa gp (sk3.ir) €36.80 3.86% 16.28%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. verallia (vrla.pa)

4.13% forward dividend yield and 38.09% return on equity

verallia société anonyme produces and sells glass packaging products for beverages and food industry worldwide. it also provides bottles for still and sparkling wines, spirits, beers, soft drinks, and oils. the company offers jars for baby food, dairy products, jams, honey, spreads, condiments, sauces, and preserves. verallia société anonyme was founded in 1827 and is based in courbevoie, france.

earnings per share

as for profitability, verallia has a trailing twelve months eps of €4.14.

pe ratio

verallia has a trailing twelve months price to earnings ratio of 9.97. meaning, the purchaser of the share is investing €9.97 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 38.09%.

moving average

verallia's worth is way above its 50-day moving average of €35.35 and way higher than its 200-day moving average of €32.34.

stock price classification

according to the stochastic oscillator, a useful indicator of overbought and oversold conditions, verallia's stock is considered to be oversold (<=20).

more news about verallia.

2. smurfit kappa gp (sk3.ir)

3.86% forward dividend yield and 16.28% return on equity

smurfit kappa group plc, together with its subsidiaries, manufactures, distributes, and sells containerboard, corrugated containers, and other paper-based packaging products in the americas and europe. the company offers e-commerce, retail, consumer, industrial, bottle, protective, heavy-duty, hexacomb, and various punnet packaging products; composite cardboard tubes, bags, and sacks; and bag-in-box, a packaging system that comprises films, accessories, bags, taps, and boxes. it also provides point of sale displays; cardboards of social distancing; corrugated sheet boards, solid board sheets, folding carton sheet boards, sack kraft papers, mg brown kraft papers, preprint products, agro-papers, technical papers, banabag, and catcher board mb12; various types of containerboards, such as kraftliners, testliners, and containerboard flutings; and solid board sheets. in addition, the company offers recycling solutions to cardboard and paper products; and supplies packaging machinery. it primarily serves consumer goods, industrial goods, and food and drink sectors. smurfit kappa group plc was founded in 1934 and is headquartered in dublin, ireland.

earnings per share

as for profitability, smurfit kappa gp has a trailing twelve months eps of €3.24.

pe ratio

smurfit kappa gp has a trailing twelve months price to earnings ratio of 11.36. meaning, the purchaser of the share is investing €11.36 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 16.28%.

volume

today's last reported volume for smurfit kappa gp is 100657 which is 82.39% below its average volume of 571589.

dividend yield

according to morningstar, inc., the next dividend payment is on sep 28, 2023, the estimated forward annual dividend rate is 1.41 and the estimated forward annual dividend yield is 3.86%.

yearly top and bottom value

smurfit kappa gp's stock is valued at €36.80 at 07:30 est, under its 52-week high of €40.17 and way above its 52-week low of €27.55.

revenue growth

year-on-year quarterly revenue growth declined by 8.6%, now sitting on 12.27b for the twelve trailing months.

more news about smurfit kappa gp.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
Q4 2026 Biopharma Catalyst Cluster: Late-Stage Readouts and Regulatory Milestones
October 2026 brings a dense run of Phase 3 wins (ALOFT-IPF, RESTORE-3), new data presentations (Roche, Bayer, Lilly, Vertex, Galderma) and regulatory steps (FDA acceptance of Roche's vamikibart BLA, Scholar Rock's EMA resubmission). The next big catalyst is the ivonescimab FDA PDUFA date on 2026-11-14. Obesity combination studies (REDEFINE 4, TOGETHER-PsO) and the 2027 Maritime-1 completion point to more catalysts ahead. QAIAx's speculative AI-linked trial claims (the QIII pilot, targeted for 2027) are an unrelated micro-cap sideshow with weak evidence, and have little in common with the large-cap pipeline news.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
ING Group
Both facts record the same metric (shares_outstanding) for ING Group at the identical observation date (2025-12-31). FACT A states 2,902,437,688 shares; FACT B states 2,902 million shares (2,902,000,000). The difference is 437,688 shares (~0.015%). This is a genuine value conflict, though the discrepancy appears to result from FACT B rounding to the nearest million while FACT A provides the precise count.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,986
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,986 facts checked against source5,377 source documents archived
Query this data → isubstrate.com